Featured Stem Cell Topics
Latest Articles
Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updatesFor about as long as I’ve been writing The Niche, people have been asking about stem cells for MS. There’s a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved…
Some CAR-T may very rarely cause new cancers
The FDA issued a statement this week that there have been reports of new cases of blood cancer after patients …
Review of Docere Clinics run by Harry Adelson including total-body injections
In today’s post, I reviewed a stem cell clinic firm called Docere Clinics. In my opinion, there are some concerning …
Weekly reads: clonal expansion, Golden Retriever cancer, FTC hits genetics firm on testi-phony-als
Let’s start this week’s digest with a discussion of clonal expansion and mutations during cell and gene therapy development. Here’s …
Weekly reads: Verve Therapeutics, Casgevy UK OK, GDNF, MYC
Some folks can view data from early, small clinical trials too skeptically or overly enthusiastically, and maybe that’s going on …
Visit Our Facebook Page
Visit our Stem Cell Channel on YouTube
Subscribe to Our Newsletter
Dr. Knoepfler’s TED talk
Authoritative stem cell information you can trust
UC Davis School of Medicine
Stem Cell Biologist & Founder
- Stem cells are all over the web, but accurate, science-based content is rare.
- Welcome to The Niche, the longest-running and #1 ranked stem cell blog.
- Award-winning cell biologist Dr. Paul Knoepfler has run the site for 12 years.
- We do stem cell research ourselves and publish papers so we’re experts.
- The Niche uniquely has no sponsored posts, and we battle dangerous hype.
- The site includes helpful resources and analysis of new papers.
- Our mission is to educate and empower.